CELC — Celcuity Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1603454 ·
Last close
$134.26
Market Cap
$6.55B
52W High
$151.02
52W Low
$100.01
ADV30
1,077,700
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -50,507,000 | -52,841,000 | 410,164,000 | 145,191,000 | 356,639,000 |
| Dec 2025 | 0 | — | -49,201,000 | -50,973,000 | 466,558,000 | 165,703,000 | 366,003,000 |
| Sep 2025 | 0 | — | -42,849,000 | -43,804,000 | 476,004,000 | 74,252,000 | 359,041,000 |
| Jun 2025 | 0 | — | -44,009,000 | -45,268,000 | 183,592,000 | 46,354,000 | 139,217,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-153,280,000
Investing CF
$-64,084,000
Financing CF
$360,552,000
CapEx
$-249,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.79
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-448,897,000
Inventory
—
Receivables
—
ST Investments
$275,794,000
EBIT TTM
$-159,894,000
Pretax Income TTM
$-177,042,000
Interest Exp TTM
$17,148,000
Analysts
10
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -172,192,000 | -177,042,000 | 466,558,000 | 366,003,000 | — | -153,280,000 |
| Dec 2024 | 0 | -113,267,000 | -111,779,000 | 245,123,000 | 129,504,000 | — | -83,467,000 |
| Dec 2023 | 0 | -66,230,331 | -63,779,116 | 191,219,398 | 51,450,076 | — | -53,812,253 |
| Dec 2022 | 0 | -39,391,091 | -40,370,040 | 175,697,097 | 41,925,630 | — | -36,008,171 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.74
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PACS | PACS Group, Inc. | $6.15B | $38.87 | — |
| CHE | CHEMED CORP | $5.81B | $437.33 | — |
| HIMS | Hims & Hers Health, Inc. | $5.32B | $23.85 | — |
| UHS | UNIVERSAL HEALTH SERVICES INC | $8.35B | $156.63 | — |
| SHC | Sotera Health Co | $4.55B | $15.96 | — |
News headlines (Yahoo Finance, 1h cache)
Delphi Diagnostics Appoints Eric Lindquist as Chief Financial Officer
2026-05-19 21:05 · Yahoo
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase
2026-05-17 20:46 · Yahoo
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares
2026-05-17 20:07 · Yahoo
Assessing Celcuity (CELC) Valuation After Positive VIKTORIA 1 Data And Upcoming FDA Decision
2026-05-16 09:18 · Yahoo
Celcuity Inc (CELC) Q1 2026 Earnings Call Highlights: Promising Clinical Trials and Strategic ...
2026-05-15 05:02 · Yahoo
Celcuity Q1 Earnings Call Highlights
2026-05-14 23:10 · Yahoo
Celcuity (CELC) Q1 2026 Earnings Transcript
2026-05-14 21:52 · Yahoo
Celcuity Inc. Reports Release of First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-14 20:01 · Yahoo
Celcuity’s Phase 3 VIKTORIA-2 Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer Expanding to Include Endocrine-Sensitive Patients
2026-05-14 11:30 · Yahoo
Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position
2026-05-10 11:59 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.